Oncology Pharma Inc.
ONPH · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 12/31/2004 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $2 | $1 | $43 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $0 | $2 | $1 | $43 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2,139 | $2,139 | $2,139 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2,139 | $2,139 | $2,139 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,139 | $2,140 | $2,140 | $43 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $778 | $773 | $690 | $290 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $261 | $243 | $227 | $199 |
| Total Curr. Liab. | $1,039 | $1,016 | $916 | $489 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,039 | $1,016 | $916 | $489 |
| Equity | – | – | – | – |
| Pref Stock | $1 | $1 | $1 | $0 |
| Common Stock | $194 | $193 | $189 | $13 |
| Retained Earnings | -$277,697 | -$277,442 | -$272,123 | -$25,842 |
| AOCI | -$194 | -$193 | -$189 | $0 |
| Other Equity | $278,796 | $278,565 | $273,345 | $25,383 |
| Total Equity | $1,100 | $1,124 | $1,224 | -$446 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,139 | $2,140 | $2,140 | $43 |
| Net Debt | $777 | $771 | $688 | $247 |